![]()
产品详情
产品名称 英文名称:Palbociclib 同义词 Palbociclib、571190-30-2、PD-0332991、Ibrance、PD0332991、PD 0332991、UNII-G9ZF61LE7G、6-acetyl-8-cyclopentyl-5-methyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)pyrido[2,3-d]pyrimidin-7(8H)-one、Palbociclib free base、G9ZF61LE7G、CHEBI85993、PD 332991、PD-332991、5711、PD0332991、6-乙酰基-8-环戊基-5-甲基-2-[[[5-(1-哌嗪基)-2-吡啶基]氨基]吡啶基[2,3-d]嘧啶-7(8H)-酮、PD991、PF 00080665、PF-00080665、PF00080665、爱博新、帕博昔利 产品性质 CAS编号:571190-30-2 分子式:C24H29N7O2 分子量:447.53 EC号:810-186-2 PubChem编号:5330286 别名:PD0332991|6-乙酰基-8-环戊基-5-甲基-2-[[[5-(1-哌嗪基)-2-吡啶基]氨基]吡啶基[2,3-d]嘧啶-7(8H)-酮|PD991|PF 00080665|PF-00080665|PF00080665|爱博新|帕博昔利 英文别名:Palbociclib|571190-30-2|PD-0332991|Ibrance|PD0332991|PD 0332991|UNII-G9ZF61LE7G|6-acetyl-8-cyclopentyl-5-methyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)pyrido[2,3-d]pyrimidin-7(8H)-one|Palbociclib free base|G9ZF61LE7G|CHEBI85993|PD 332991|PD-332991|5711 规格或纯度:≥99% 英文名称:Palbociclib 生化机理:Palbociclib (PD-0332991) is an orally available pyridopyrimidine-derived cyclin-dependent kinase (CDK) inhibitor with potential antineoplastic activity. Palbociclib is a highly specific inhibitor of cyclindependent kinase 4 (Cdk4) (IC50, 0.011 μmol/L) and Cdk6 (IC50, 0.016 μmol/L), having no activity against a panel of 36 additional protein kinases.Potent, highly specific inhibitor of Cdk4 (IC 50 = 11 nM) and Cdk6 (IC 50 = 16 nM). Displays selectivity for Cdk4/6 over a panel of 36 additional protein kinases (IC 50 values are > 10\xa0μM).\xa0 Induces G 1 cell cycle arrest and senescence in retinoblas 储存温度:-20°C储存 运输条件:超低温冰袋运输 备注:如果有可能,您尽量在使用的当天配置溶液,并在当天使用完它。但是,如果您需要预先配制储备溶液,我们建议您将溶液等份保存在-20°C的密封小瓶中。通常,它们最多可以使用一个月。在使用前和打开样品瓶之前,我们建议您让您的产品在室温下平衡至少1小时。需要更多关于溶解度,用法和处理的建议吗?请访问我们的常见问题(FAQ)页面以获取更多详细信息。 产品介绍:Palbociclib (PD-0332991) is an orally available pyridopyrimidine-derived cyclin-dependent kinase (CDK) inhibitor with potential antineoplastic activity. ALogP:1.8 PubChem SID:488195370 PubChem SID url:https//pubchem.ncbi.nlm.nih.gov/substance/488195370 IUPAC Name:6-acetyl-8-cyclopentyl-5-methyl-2-[(5-piperazin-1-ylpyridin-2-yl)amino]pyrido[2,3-d]pyrimidin-7-one INCHI:InChI=1S/C24H29N7O2/c1-15-19-14-27-24(28-20-8-7-18(13-26-20)30-11-9-25-10-12-30)29-22(19)31(17-5-3-4-6-17)23(33)21(15)16(2)32/h7-8,13-14,17,25H,3-6,9-12H2,1-2H3,(H,26,27,28,29) InChi Key:AHJRHEGDXFFMBM-UHFFFAOYSA-N Canonical SMILES:CC1=C(C(=O)N(C2=NC(=NC=C12)NC3=NC=C(C=C3)N4CCNCC4)C5CCCC5)C(=O)C Isomeric SMILES:CC1=C(C(=O)N(C2=NC(=NC=C12)NC3=NC=C(C=C3)N4CCNCC4)C5CCCC5)C(=O)C 关联CAS:571190-30-2 PubChem CID:5330286 MeSH Entry Terms:6-acetyl-8-cyclopentyl-5-methyl-2-(5-piperazin-1-ylpyridin-2-ylamino)-8H-pyrido(2,3-d)pyrimidin-7-one;Ibrance;palbociclib;PD 0332991;PD-0332991;PD0332991 ChEMBL Ligand:CHEMBL189963 CAS Registry No.:571190-30-2 Wikipedia:Palbociclib RCSB PDB Ligand:LQQ PEP:palbociclib DrugCentral Ligand:4941 溶解性:DMSO 象形图: 信号词:Danger 危险声明:H301 Toxic if swallowedH341 Suspected of causing genetic defectsH373 Causes damage to organs through prolonged or repeated exposureH411 Toxic to aquatic life with long lasting effectsH302 Harmful if swallowedH372 Causes damage to organs through prolonged or repeated exposureH360 May damage fertility or the unborn childH361 Suspected of damaging fertility or the unborn child 预防措施声明:P273,P280,P321,P405,P501,P264,P260,P281,P270,P391,P330,P203,P301+P316,P301+P317,P318,P319 产品包装
免责声明:以上所展示的信息由企业自行提供,内容的真实性
、准确性和合法性由发布企业负责,chemdig对此不承担任何保证责任。 同时我们郑重提醒各位买/卖家,
交易前 请详细核实对方身份,切勿随意打款或发货,谨防上当受骗。如发现虚假信息,请向chemdig举报。 |
上海阿拉丁生化科技股份有限公司
|
上海阿拉丁生化科技股份有限公司
邮箱 | market@aladdin-e.com |
联系人 | 18521732826 |
咨询请告知是在ChemDig上看到的,有助于交易达成。